1. Home
  2. POOL vs MIRM Comparison

POOL vs MIRM Comparison

Compare POOL & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pool Corporation

POOL

Pool Corporation

HOLD

Current Price

$195.61

Market Cap

7.0B

ML Signal

HOLD

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

HOLD

Current Price

$107.77

Market Cap

5.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
POOL
MIRM
Founded
1993
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.0B
5.7B
IPO Year
1997
2019

Fundamental Metrics

Financial Performance
Metric
POOL
MIRM
Price
$195.61
$107.77
Analyst Decision
Hold
Strong Buy
Analyst Count
10
13
Target Price
$274.43
$119.85
AVG Volume (30 Days)
1.2M
685.0K
Earning Date
04-23-2026
05-06-2026
Dividend Yield
2.38%
N/A
EPS Growth
N/A
74.59
EPS
1.45
N/A
Revenue
$5,289,396,000.00
$19,138,000.00
Revenue This Year
$4.30
$26.22
Revenue Next Year
$3.84
$22.04
P/E Ratio
$137.23
N/A
Revenue Growth
N/A
N/A
52 Week Low
$172.68
$47.89
52 Week High
$345.00
$114.99

Technical Indicators

Market Signals
Indicator
POOL
MIRM
Relative Strength Index (RSI) 53.35 65.48
Support Level $174.74 $87.93
Resistance Level $250.38 $114.99
Average True Range (ATR) 7.66 3.92
MACD 2.07 1.37
Stochastic Oscillator 62.15 85.84

Price Performance

Historical Comparison
POOL
MIRM

About POOL Pool Corporation

Pool Corp is a wholesale distributor of swimming pool supplies, equipment, and related leisure products. The company's products include pool pumps, filters, heaters, and cleaners; pool maintenance products like chemicals, supplies, and repair parts; irrigation and landscape maintenance products; and outdoor lighting, grills, outdoor kitchen components, etc. These products are offered through branded distribution networks such as Horizon, SCP, Poolcorp Commercial Aquatics, Sun Wholesale Supply, Superior Pool Products, and NPT. The company's customers include pool builders, pool service companies, retail stores, commercial pool operators, and landscape contractors. Geographically, it generates maximum revenue from the United States, followed by other markets like Europe and Australia.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.

Share on Social Networks: